open access

Vol 58, No 1 (2007)
Original papers
Published online: 2007-01-31
Submitted: 2013-02-15
Get Citation

Osteoprotegerin - does it play a protective role in the pathogenesis of bone loss in obese perimenopausal women?

Michał Holecki, Barbara Zahorska-Markiewicz, Joanna Janowska, Katarzyna Mizia-Stec, Agnieszka Żak-Gołąb, Magdalena Olszanecka-Glinianowicz, Katarzyna Wojaczyńska-Stanek, Teresa Nieszporek, Andrzej Więcek
Endokrynologia Polska 2007;58(1):7-10.

open access

Vol 58, No 1 (2007)
Original papers
Published online: 2007-01-31
Submitted: 2013-02-15

Abstract


Introduction: Assessment of serum osteoprotegerin (OPG) concentrations in obese patients in comparison to healthy controls and evaluation of a possible correlation between OPG and other markers of bone turnover or calcitropic hormones.
Material and methods: 50 obese perimenopausal women without concomitant diseases (BMI 36.7 ± 4.1 kg/m², mean age 50.4 ± 4.9 yrs). The control group consisted of 19 healthy women (BMI 24.2 ± 2.1 kg/m²; mean age 53.8 ± 5.1 yrs). In all patients serum concentration of OPG, C telopeptide of type I collagen containing the crosslinking site (CTX), osteocalcin, parathormone (PTH) and vitamin D (25-OH-D3) was assessed. Dual energy x-ray absorptiometry (the DXA method) of the lumbar spine and femoral neck was performed using a Lunar DPXL to measure bone marrow density (BMD).
Results: In obese perimenopausal women serum OPG, osteocalcin and 25-OH-D3 levels were significantly lower, and the serum PTH level was significantly higher in comparison to healthy controls. A significantly positive correlation was found between serum OPG level and age in both obese and control subjects.
Conclusion: The serum OPG level in obese perimenopausal women is significantly lower in comparison to healthy controls and does not correlate significantly with biochemical markers of bone turnover, calcitropic hormones and BMD. It probably cannot play a protective role in the pathogenesis of bone loss in obese perimenopausal women.

Abstract


Introduction: Assessment of serum osteoprotegerin (OPG) concentrations in obese patients in comparison to healthy controls and evaluation of a possible correlation between OPG and other markers of bone turnover or calcitropic hormones.
Material and methods: 50 obese perimenopausal women without concomitant diseases (BMI 36.7 ± 4.1 kg/m², mean age 50.4 ± 4.9 yrs). The control group consisted of 19 healthy women (BMI 24.2 ± 2.1 kg/m²; mean age 53.8 ± 5.1 yrs). In all patients serum concentration of OPG, C telopeptide of type I collagen containing the crosslinking site (CTX), osteocalcin, parathormone (PTH) and vitamin D (25-OH-D3) was assessed. Dual energy x-ray absorptiometry (the DXA method) of the lumbar spine and femoral neck was performed using a Lunar DPXL to measure bone marrow density (BMD).
Results: In obese perimenopausal women serum OPG, osteocalcin and 25-OH-D3 levels were significantly lower, and the serum PTH level was significantly higher in comparison to healthy controls. A significantly positive correlation was found between serum OPG level and age in both obese and control subjects.
Conclusion: The serum OPG level in obese perimenopausal women is significantly lower in comparison to healthy controls and does not correlate significantly with biochemical markers of bone turnover, calcitropic hormones and BMD. It probably cannot play a protective role in the pathogenesis of bone loss in obese perimenopausal women.
Get Citation

Keywords

osteoprotegerin; obesity; bone turnover; calcitropic hormones; BMD

About this article
Title

Osteoprotegerin - does it play a protective role in the pathogenesis of bone loss in obese perimenopausal women?

Journal

Endokrynologia Polska

Issue

Vol 58, No 1 (2007)

Pages

7-10

Published online

2007-01-31

Bibliographic record

Endokrynologia Polska 2007;58(1):7-10.

Keywords

osteoprotegerin
obesity
bone turnover
calcitropic hormones
BMD

Authors

Michał Holecki
Barbara Zahorska-Markiewicz
Joanna Janowska
Katarzyna Mizia-Stec
Agnieszka Żak-Gołąb
Magdalena Olszanecka-Glinianowicz
Katarzyna Wojaczyńska-Stanek
Teresa Nieszporek
Andrzej Więcek

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl